Navigation Links
Mesh Lawsuit – Bellwether Cases Selected in Federal Litigation Underway for Ethicon Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) July 28, 2013

Mesh lawsuit claims involving transvaginal mesh products marketed by Johnson & Johnson’s Ethicon, Inc. unit continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order issued on July 25th, the Court has designated four Ethicon transvaginal mesh lawsuits for the proceedings’ first two rounds of bellwether trials. The first round of trials is scheduled to begin on January 14, 2014, while the second will commence on May 27, 2014. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)

“We look forward to the start of bellwether trials in the federal Ethicon mesh lawsuits, as the outcome of these cases will help us evaluate claims in similar lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in the federal Ethicon mesh litigation. Bernstein Liebhard LLP continues to review transvaginal mesh lawsuits on behalf of women allegedly injured by pelvic mesh products marketed by Ethicon, Inc. and other manufacturers.

Ethicon Mesh Lawsuits
Court documents indicate that more than 8,460 transvaginal mesh lawsuits have been filed in the federal proceeding underway in West Virginia. All of the claims pending in the litigation allege that Ethicon failed to provide adequate warnings regarding the risks associated with Gynecare pelvic mesh products used to treat pelvic organ prolapse and stress urinary incontinence. It is further alleged that plaintiffs suffered a variety of serious complications due to the defective nature of these products, including chronic infections, organ damage, and mesh erosion and shrinkage.

Transvaginal mesh devices and related complications have been the subject of two U.S. Food & Drug Administration (FDA) Public Safety Alerts since October 2008.* While Ethicon has never announced a mesh recall for any of the Gynecare products involved in the litigation, the company did announce in June 2012 that it would stop sales of some of those device due to commercial concerns.**

Ethicon is just one of several pelvic mesh manufacturers facing litigation over these devices in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees for proceedings involving American Medical Systems, Inc. (MDL No. 2325) Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187). Court documents show that the first of the litigations’ bellwether trials, involving a C.R. Bard product, is scheduled to begin on July 29, 2013.

Mr. Grand has also been named Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon transvaginal mesh lawsuits that are currently underway in New Jersey’s Atlantic County Superior Court. He was also a member of the trial team on the first Ethicon trial in that proceeding, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women who have allegedly suffered serious complications associated with transvaginal mesh may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding transvaginal mesh lawsuits is available at Bernstein Liebhard's website. To arrange for a free mesh lawsuit review with an experienced medical device attorney, please contact the Firm today by calling 800-511-5092.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(800) 511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (800) 511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Skechers Lawsuit Filed on Behalf of New Mexico Woman Alleges that the Defective Design of Shape-Ups Caused Her Severe Arm and Knee Injuries, Reports Wright & Schulte
2. Actos Lawsuit – Status Conference Convened in Federal Actos Bladder Cancer Multidistrict Litigation, Bernstein Liebhard LLP Reports
3. Cerebral Palsy and Medical Malpractice Lawsuit Allegations Update: Resource4thePeople Reports New Study Finds Cerebral Palsy, other Birth Defects Risk Increase with Assisted Conception
4. Byetta Lawsuit - Claims Move Forward, as Panel Considers Consolidation of Federal Claims Involving Byetta and Similar Diabetes Drugs, Bernstein Liebhard LLP Reports
5. Actos Lawsuit News: More Than a Dozen Lawsuits Filed in West Virginia, Rottenstein Law Group LLP Reports
6. Mesh Lawsuit - First Bellwether Trial in Federal C.R. Bard Transvaginal Mesh Litigation Set to Begin Monday, Bernstein Liebhard LLP Reports
7. Rottenstein Law Group LLP Announces Launch of Stryker Lawsuit Center
8. Flood Law Group to Sponsor
9. Judge Denies Medtronic’s Bid to Dismiss Lawsuit Alleging that the Off-Label Usage of its Infuse Bone Growth Product Caused Disability, Parker Waichman LLP Notes
10. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
11. Actos Bladder Cancer Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Actos Litigation
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: